
|Articles|March 1, 1998
The American Journal of Managed Care
- March 1998
- Volume 4
- Issue 3
Economic Outcomes Associated with the Use of Risperidone in a Naturalistic Group Practice Setting
Advertisement
Articles in this issue
almost 28 years ago
A Cost-Effectiveness Clinical Decision Analysis Model for Schizophreniaalmost 28 years ago
Treatment of Schizophrenia: Let's Talk Dollars and Sensealmost 28 years ago
Maintaining Skeletal Health Among Postmenopausal Womenalmost 28 years ago
Work-up for Diverticulitisalmost 28 years ago
Screening and Surveillance for Colorectal Canceralmost 28 years ago
Parenteral and Enteral Nutrition in the Home and Chronic Care SettingsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AI-Supported Mammography Caught More Cancers During Screening
2
Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026
3
The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine
4
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
5









